Erratum: A pilot clinical trial of a recombinant ricin vaccine in normal humans (Proceedings of The National Academy of Sciences of the United States of America (February 14, 2006) 103, 7 (2268-2273) 10.1073/pnas.0510893103);A pilot clinical trial of a recombinant ricin vaccine in normal humans

Proceedings of the National Academy of Sciences of the United States of America

Volumn 103, Issue 7, 2006, Pages 2268-2273

  Vitetta, Ellen S ^a,b   Smallshaw, Joan E ^a   Coleman, Elaine ^a   Jafri, Hasan ^a   Foster, Callie ^a   Munford, Robert ^a   Schindler, John ^a  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^b UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; CREATINE KINASE; LECTIN; NEUTRALIZING ANTIBODY; RECOMBINANT RICIN VACCINE; RECOMBINANT VACCINE; RICIN; RICIN ANTIBODY; RIVAX; UNCLASSIFIED DRUG;

ADULT; ALLERGY; AMINO ACID SUBSTITUTION; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY RESPONSE; ANTIBODY TITER; ARTICLE; CHILL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG APPROVAL; DRUG MEGADOSE; DRUG SAFETY; ESCHERICHIA COLI; FEMALE; FOOD AND DRUG ADMINISTRATION; HEADACHE; HUMAN; HUMAN CELL; HUMAN EXPERIMENT; HUMAN TISSUE; INJECTION SITE DISCOMFORT; INJECTION SITE ERYTHEMA; INJECTION SITE IRRITATION; INJECTION SITE NODULE; INJECTION SITE WARMTH; INJECTON SITE CONTUSION; INTOXICATION; LECTIN BINDING SITE; LIVER FUNCTION TEST; LOW DRUG DOSE; MALE; MOLECULAR STABILITY; MOUSE; MYALGIA; NAUSEA; NONHUMAN; NORMAL HUMAN; NOSE CONGESTION; PRIORITY JOURNAL; RABBIT; RICINUS COMMUNIS; SINUSITIS; SORE THROAT; VACCINATION; VASCULAR DISEASE; VASCULAR LEAK SYNDROME;

ANIMALIA; ESCHERICHIA COLI; ORYCTOLAGUS CUNICULUS; RICINUS COMMUNIS;

EID: 33144473223     PISSN: 00278424     EISSN: None     Source Type: Journal    
DOI: 10.1073/pnas.0601105103     Document Type: Erratum

References (43)

1. Barbieri, L., Battelli, M. G. & Stirpe, F. (1993) Biochim. Biophys. Acta 154, 237-282.
2. Rauber, A. & Heard, J.-M. (1985) Vet. Hum. Toxicol. 27, 498-502.
3. Flexner, J. (1897) J. Exp. Med. 2, 216.
4. Eiklid, K., Olsnes, S. & Pihi, A. (1980) Exp. Cell Res. 126, 321-326.
5. Olson, M. A. (1997) Proteins 27, 80-95.
6. Montfort, W., Villafranca, J. E., Monzingo, A. F., Ernst, S. R., Katzin, B. J., Rutenber, E., Xuong, N. H., Hamlin, R. & Robertus, J. D. (1987) J. Biol. Chem. 262, 5398-5403.
7. Rutenber, E. & Robertus, J. D. (1991) Proteins 10, 260-269.
8. Rutenber, E., Katzin, B. J., Ernst, S., Collins, E. J., Mlsna, D., Ready, M. P. & Robertus, J. D. (1991) Proteins 10, 240-250.
9. Olsnes, S. (2004) Toxicon 44, 361-370.
10. Ishiguro, M., Tomi, M., Funatsu, G. & Funatsu, M. (1976) Toxicon 14, 157-165.
11. Franz, D. R. & Jaax, N. K. (1997) in Textbook of Military Medicine, eds. Zajtchuk, R. & Bellamy, R. F. (Office of the Surgeon General at TMM Publications, Borden Inst., Walter Reed Army Medical Center, Washington, DC), pp. 631-642.
12. Thorpe, P. E., Detre, S. I., Foxwell, B. M. J., Brown, A. N. F., Skilleter, D. N., Wilson, G., Forrester, J. A. & Stirpe, F. (1985) Eur. J. Biochem. 147, 197-206.
13. Centers for Disease Control and Prevention (2000) Morbid. Mortal Wkly. Rep. 49, 1-14.
14. Smallshaw, J. E., Richardson, J. A., Pincus, S. H., Schindler, J. & Vitetta, E. S. (2005) Vaccine 23, 4775-4784.
15. Smallshaw, J. E., Firan, A., Fulmer, J. R., Ruback, S. L., Ghetie, V. & Vitetta, E. S. (2002) Vaccine 20, 3422-3427.
16. Kim, Y. & Robertus, J. D. (1992) Protein Eng. 8, 775-779,
17. Ready, M. P., Kim, Y. S. & Robertus, J. D. (1991) Proteins Struct. Funct. Genet. 10, 270-278.
18. Simpson, J. C., Lord, J. M. & Roberts, L. M. (1995) Eur. J. Biochem. 232, 458-463.
19. Baluna, R., Rizo, J., Gordon, B. E., Ghetie, V. & Vitetta, E. S. (1999) Proc. Natl. Acad. Sci. USA 96, 3957-3962.
20. Hunter, R. L. (2002) Vaccine 20, S7-S12.
21. Hilleman, M. R. (2000) Vaccine 18, 1436-1447.
22. Robbins, J. B., Schneerson, R., Trollfors, B., Sato, H., Sato, Y. & Rappuoli, R. (2005) J. Infec. Dis. 191, 81-88.
23. Jefferson, T., Rudin, M. & Di Pietrantonj, C. (2004) Lancet 4, 84-90.
24. DeHaan, R. M., Schellenberg, D. & Sobota, J. T. (1974) J. Clin. Pharmacol 14, 183-191.
25. Maddaloni, M., Cooke, C., Wilkinson, R., Stout, A. V., Eng, L. & Pincus, S. H. (2004) J. Immunol. 172, 6221-6228.
26. Griffiths, G. D., Bailey, S. C., Hambrook, J. L. & Keyte, M. P. (1998) Vaccine 16, 530-535.
27. Marsden, C. J., Knight, S., Smith, D. C., Day, P., Roberts, L. M., Phillips, G. J. & Lord, J. M. (2004) Vaccine 22, 2800-2805.
28. Vitetta, E. S. (2000) Cancer J. 65, S218-S224.
29. Tommasi, M., Castelletti, D. & Pasti, M. (2001) Clin Exp. Immunol. 125, 391-400.
30. Castelletti, D., Fracasso, G., Righetti, S., Tridente, G., Schnell, R., Engert, A. & Colombatti, M. (2004) Clin. Exp. Immunol. 136, 365-372.
31. World Health Organization (1998) Fifty Facts from the World Health Report 1998: Global Health Situations and Trends 1955-2025 (W.H.O., Geneva).
32. Stills, H. F. (2005) ILAR J. 46, 280-293.
33. Lindblad, E. B. (2004) Immunol. Cell Biol. 82, 497-505.
34. Myers, M., Beckman, C., Voadingh, R. & Hankins, W. (1982) J. Am. Med. Assoc. 248, 2478-2480.
35. Shouval, D. (2003) J. Hepatol. 39, S70-S76.
36. Smith, J. W. (2005) Br. Med. Bull. 25, 177-182.
37. Hewetson, J. F., Rivera, V. R., Creasia, D. A., Lemley, P. V., Rippy, M. K. & Poli, M. A. (1993) Vaccine 11, 743-746.
38. Olson, M. A., Carra, J. H. & Roxas-Duncan, V. (2004) Protein Engineering Des. Selection 17, 391-397.
39. Kende, M., Yan, C., Hewetson, J. F., Frick, M., Rill, W. & Tammariello, R. (2002) Vaccine 20, 1681-1691.
40. Mantis, N. J. (2005) Adv. Drug Deliv. Rev. 57, 1424-1439.
41. Griffiths, G. D. & Lindsay, C. D. (1995) Hum. Exp. Toxicol. 14, 155-164.
42. Griffiths, G. D., Phillips, G. J. & Bailey, S. C. (1999) Vaccine 17, 2562-2568.
43. Poli, M. A., Rivera, V. R., Pitt, M. L. & Vogel, P. (1996) Toxicon 34, 1037-1044.